Across TCGA pan-cancer cohorts, AKR1B10P2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of AKR1B10P2’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where AKR1B10P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types AKR1B10P2 is over-expressed in tumor.
LUSC are the cancer types where AKR1B10P2 tumor–normal differential expression is most reproducible.